Pathogenesis of prostate cancer: lessons from basic research
- PMID: 21603505
- PMCID: PMC3096366
Pathogenesis of prostate cancer: lessons from basic research
Abstract
In the United States, prostate cancer is the second most common cause of cancer-related deaths in men. While the importance of androgens and androgen receptors (ARs) in primary prostate cancer is well established, the role of ARs in prostate cancers that emerge despite androgen ablation therapies remains poorly understood. The aim of this article is to illustrate the fundamental biology of prostate cancer. We focus mainly on the AR because of its critical role in the progression and metastatic spread of prostate cancer. We also summarize the alternate pathways that may potentially contribute to the progression of prostate cancer. Identifying the underlying mechanisms of androgen independence is crucial in the design of appropriate therapies for hormone-refractory neoplasms.
Keywords: adenocarcinoma; androgen receptor; hormone resistance; prostate; signaling pathways; testosterone.
Figures



References
-
- Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA: Cancer J Clin. 2008;58:71–96. - PubMed
-
- Walcott J. L., Merry D. E. Trinucleotide repeat disease. The androgen receptor in spinal and bulbar muscular atrophy. Vitam Horm. 2002;65:127–147. - PubMed
-
- Casella R., Maduro M. R., Lipshultz L. I., Lamb D. J. Significance of the polyglutamine tract polymorphism in the androgen receptor. Urology. 2001;58:651–656. - PubMed
-
- Agoulnik I. U., Weigel N. L. Androgen receptor action in hormone-dependent and recurrent prostate cancer. J Cell Biochem. 2006;99:362–372. - PubMed
-
- Edwards J., Bartlett J. M. The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor. BJU Int. 2005;95:1320–1326. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials